FDA approves Stivarga for GIST
Familiar with GIST?
gastrointestinal stromal tumors
GIST
Today, the FDA announced the approval of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.
Learn more here.
Source: Medicine and Technology by Dr. Joseph Kim - Category: Technology Consultants Tags: FDA new drugs oncology cancer Novartis Source Type: blogs